Dolby Laboratories Valuation Analysis
| DLB Stock | USD 57.46 -0.01 -0.02% |
Below Model Estimate
Today
The intrinsic value estimate for Dolby Laboratories is based on a 3 months horizon. Extending the time horizon generally improves valuation stability.
The valuation of Dolby Laboratories depends on whether margins, cash generation, and capital structure support current pricing. Comparing multiple valuation approaches and benchmarking against peers establishes whether current pricing aligns with Dolby Laboratories' earnings profile and risk structure. A valuation rooted in multiple frameworks is less likely to overweight a single assumption about Dolby Laboratories's future trajectory. Benchmarking against peers produces the most actionable estimate of Dolby Laboratories' value.
Main Profitability Drivers
The latest figures show Dolby Laboratories' net profit margin at 16.00% and operating margin at 30.00%. The 14.00 percentage-point gap between operating and net margins points to non-operating costs such as interest expense or taxes reducing bottom-line profitability. From $1.35 billion in revenue, Dolby Laboratories retained $1.19 billion after cost of goods and reported $256.49 million in net income. With ROE at 15.00% and ROA at 11.00%, these return measures help contextualize Dolby Laboratories' profitability relative to its balance sheet. Overall, Dolby Laboratories' profitability indicators are trending favorably, with a majority of key metrics improving year over year. View Dolby Laboratories' full profitability analysis for additional context.
Price Book 2.11 | Gross Profit | Price Sales 4.02 | Profit Margin | Enterprise Value Revenue 3.65 |
Dolby Laboratories Cash | $528.48 million |
Cash stood at $807.18 million as of December 31, 2025.
Revenue by Product
Dolby Laboratories' reported product mix includes 6 disclosed revenue streams. The reported segment mix is led by Licensing, Brodcast Revenue at 119.2 million, followed by Licensing, Mobile Revenue at 94.24 million. The reported segment mix is best read as directional context rather than a full bridge to consolidated revenue.Dolby Laboratories operates as a hardware technology company generating revenue through device sales, enterprise demand, and product cycles. Positioned as a growth-weighted stock within Electronic Equipment, Instruments & Components, its earnings multiple reflects expectations for durable earnings expansion and platform-level economics. The sections below test current market pricing against capital structure, margins, and earnings trajectory.
Total Value Analysis
Dolby Laboratories currently shows enterprise value of 4.98 billion, market capitalization of 5.48 billion, debt of 38.88 million, and cash and equivalents of 616.41 million as of latest reporting. The gap between enterprise value and market cap reflects the net effect of debt and cash — shifts in either can materially change the total-value picture.| Takeover Price | Market Cap | Debt Obligations | Cash & Equivalents |
4.98 billion | 5.48 billion | 38.88 million | 616.41 million |
Investor Information
About 98.0% of DLB shares are held by institutions such as insurance companies. The book value of DLB was currently reported as 27.68. DLB has Price/Earnings To Growth (PEG) ratio of 2.08. Dolby Laboratories had its last dividend issued on the 12th of May 2026. Current financial indicators suggest moderate financial flexibility with thin profitability in asset utilization and capital deployment. Operating returns remain positive, supporting continued earnings capacity.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 30.00% | 17.33% |
|
| |||||
| Total Cash From Operating Activities | $322.64 million | $543.03 million |
|
| |||||
| Operating Income | $249.74 million | $304.7 million |
|
|
Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Dolby Laboratories has an asset utilization ratio of 41.8 percent. This suggests that the Company is making $0.42 for each dollar of assets. An increasing asset utilization means that Dolby Laboratories is more efficient with each dollar of assets it utilizes for everyday operations.Macro event markers
Discounted Cash Flow Analysis
On the current custom levered DCF assumptions, Dolby Laboratories is valued at about 90.27 per share while the stock changes hands near 57.47. The market is pricing the shares around 57.1% under the model estimate. The setup uses a WACC of 8.06% and a long-term growth rate of 4.0%, with next-period free cash flow around 397.80 Million. Discounted forecast cash flows sum to about 1.48 Billion before the terminal component, and present terminal value still represents roughly 81.8% of enterprise value. Terminal value driving 81.8% of the total means the output is heavily influenced by perpetual growth and discount rate assumptions beyond the explicit forecast horizon.Model Value / Share
90.27
Equity value per share from the current custom levered DCF summary row.
Market Price
57.47
Current market price used by the same scenario.
Model Upside
57.1%
Market price sits below the model output.
WACC / LT Growth
8.06% / 4.0%
Forecast horizon: 2021 to 2030Terminal value share of EV: 81.8%
Dolby Market Price vs. Intrinsic Value
This chart compares observed market pricing with the model-derived equity value per share across forecast periods. It also illustrates the relative premium or discount, expressed as a percentage difference between market valuation and modeled intrinsic value.
Projected Revenue and Levered Free Cash Flow
Revenue and levered free cash flow projections are presented in billions, outlining the expected financial trajectory over the modeled horizon.
Key Model Assumptions
The inputs below reflect the core assumptions applied in the valuation model, including growth expectations, discount rates, and capital structure considerations.
| Input | Current Value |
|---|---|
| Weighted Average Cost of Capital | 8.06% |
| Long-Term Growth Rate | 4.0% |
| Cost of Equity | 8.09% |
| After-Tax Cost of Debt | 3.39% |
| Debt Weighting | 0.69% |
| Equity Weighting | 99.31% |
| Net Debt | -663.01 million |
| Enterprise Value | 8.14 billion |
| Present Terminal Value | 6.65 billion |
| Terminal Value Share of EV | 81.8% |
Forecast Detail and Valuation Progression
This table presents the underlying forecast data used in the valuation, including revenue, cash flow generation, discounting effects, and the resulting per-share value across each projected period.
| Year | Revenue | Revenue Growth | Free Cash Flow | PV of LFCF | Equity Value / Share |
|---|---|---|---|---|---|
| 2021 | 1.28 billion | 0.00% | 393.3 million | 0 | 90.27 |
| 2022 | 1.25 billion | -2.14% | 259.12 million | 0 | 90.27 |
| 2023 | 1.3 billion | 3.66% | 336.74 million | 0 | 90.27 |
| 2024 | 1.27 billion | -2.00% | 297.25 million | 0 | 90.27 |
| 2025 | 1.35 billion | 5.92% | 430.26 million | 0 | 90.27 |
| 2026 | 1.37 billion | 1.36% | 362.38 million | 335.36 million | 90.27 |
| 2027 | 1.39 billion | 1.36% | 367.31 million | 314.57 million | 90.27 |
| 2028 | 1.4 billion | 1.36% | 372.3 million | 295.08 million | 90.27 |
| 2029 | 1.42 billion | 1.36% | 377.37 million | 276.79 million | 90.27 |
| 2030 | 1.44 billion | 1.36% | 382.5 million | 259.63 million | 90.27 |
Profitability Analysis
Based on Dolby Laboratories' financial statements, Dolby Laboratories is profitable with a net margin of 16.0% and operating margin of 30.0%, reporting net income of 256.49 million. Return on equity stands at 15.0%. Profitability trends are broadly favorable, with a majority of key metrics improving year over year.Net Income | First Reported 2002-12-31 | Previous Quarter 53.33 million | Current Value 94.92 million | Quarterly Volatility 28.87 million |
Macro event markers
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 67.00% | 88.73% |
|
| |||||
| Net Profit Margin | 16.00% | 14.68% |
|
| |||||
| Operating Profit Margin | 30.00% | 17.33% |
|
| |||||
| Pretax Profit Margin | 31.00% | 17.17% |
|
| |||||
| Return On Assets | 11.00% | 6.81% |
|
| |||||
| Return On Equity | 15.00% | 8.20% |
|
|
Dolby Laboratories profitability is assessed through margins, return on equity, and asset efficiency. Net margin of 16.0% reflects solid earnings conversion and cost discipline relative to revenue. Margin trends and return metrics below indicate whether the earnings profile is strengthening or deteriorating. Dolby Laboratories reports return on equity of 15.0%, positive but not at levels that signal strong capital efficiency.
Earnings per Share Projection vs Actual
EPS projections for Dolby Laboratories aggregate analyst models into a benchmark against which actual results are measured. Return on equity of 9.42% provides context for how efficiently Dolby Laboratories generates earnings from shareholder capital. The gap between Dolby Laboratories' EPS and free cash flow per share signals how much of reported earnings converts to cash. Dolby Laboratories' EPS estimates are updated as new analyst reports and company disclosures become available. The EPS consensus for Dolby Laboratories reflects normalized analyst expectations. Comparing this estimate against the current net margin profile (16.0%), guidance revisions, and prior forecast error reveals whether the market is pricing in improvement, stability, or deterioration. Dolby Laboratories reported estimated earnings of 0.67 in earnings per share on 30th of June 2026. This estimate serves as the benchmark against which the next reported result will be judged by the market.Macro event markers
Earnings Estimation Breakdown
4 analysts contribute to the current consensus. The last reported EPS was 1.37 as of 31st of March 2026.
Last Reported EPS
0.67
Lowest
0.67
Expected EPS
0.67
Highest
Analyst estimate range around the current expected EPS projection.
Earnings Projection Consensus
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 30th of June 2026 | Current EPS (TTM) | |
| 4 | 86.08% | 1.37 | 0.67 | 2.52 |
Ownership Allocation
The majority of Dolby Laboratories' outstanding shares are owned by institutional holders. High institutional ownership often reflects the stock's eligibility for passive index funds, which are required to hold positions proportional to index weights regardless of their own investment view. Active managers holding Dolby Laboratories must also disclose positions above certain thresholds through SEC filings.Revenue and Profit Overview
DLB reported last year's revenue of $1.35 billion. Total Income to common stockholders was $256.49 million with profit before taxes, overhead, and interest of $1.19 billion.Historical Distributions to Stockholders
Changes in dividend policy at Dolby Laboratories may influence how investors interpret its financial outlook. Analysts often examine dividend payments relative to free cash flow and net income trends. To better understand payout patterns, it may help to see how Dolby Laboratories distributes income.
| 18th of February 2026 | ||
| 10th of December 2025 | ||
| 20th of August 2025 | ||
| 21st of May 2025 | ||
| 19th of February 2025 | ||
| 10th of December 2024 | ||
| 27th of August 2024 | ||
| 22nd of May 2024 |
What the Data Shows
The 23.36 earnings multiple places Dolby Laboratories at a level where the market is pricing in steady earnings continuation rather than aggressive growth or contraction. Margins of 16.0% are adequate but not exceptional - competitive dynamics or cost shifts in either direction could move the profitability picture meaningfully. Conservative leverage at 0.02 gives Dolby Laboratories significant balance-sheet flexibility to support future investment or weather economic stress. Dolby Laboratories earns 15.0% on equity - positive but moderate, indicating productive capital deployment without the kind of returns that signal strong competitive advantages. Current pricing embeds an expectation of steady earnings performance roughly in line with historical trends. A shift in forward earnings expectations and sector dynamics would alter the balance between what the market has priced in and what ultimately materializes.
Combined Signal Overview
The financial profile frames Dolby Laboratories as an asset-light business model with strong pricing power and limited dependence on balance sheet leverage in the Electronic Equipment, Instruments & Components sector. The earnings and capital-return profile places the company within the mid-range of its peer group, with performance that supports but does not clearly exceed current valuation levels. The data points to a fundamentally sound business - Dolby Laboratories's valuation is well supported at current levels, with the forward trajectory tied to forward earnings expectations and sector dynamics.
The analysis above provides a structured baseline for Dolby Laboratories that becomes more informative as new data arrives. Given the current mix of multiples, margins, and leverage, the valuation picture is most useful when tracked over time rather than read as a static conclusion.
Valuation Framework, Methodology & Assumptions
Dolby Laboratories is a mid-cap equity in Electronic Equipment, Instruments & Components, Technology Hardware & Equipment, Information Technology categories. Capital structure affects intrinsic modeling assumptions. Current valuation multiples for Dolby Laboratories include P/E of 23.36.
Dolby Laboratories analytics rely on periodic company reporting and market reference feeds, with quality checks and normalization applied. Sell-side coverage, where present, supplements the data shown. Valuation outputs are model-derived and depend on published assumptions and reference inputs.
The analysis above is generated by quantitative models and is provided for informational and educational purposes only. It does not constitute financial advice, investment recommendations, or an endorsement to buy or sell any security. All investing involves risk, including the possible loss of principal. Consult a qualified financial advisor before making investment decisions. See our Terms of Use for full details.
Financial data referenced in this analysis is derived from publicly available SEC filings, audited financial statements, and third-party market data providers. The intrinsic value estimate is generated by Macroaxis quantitative models that incorporate fundamental analysis, technical indicators, and risk metrics.
The methodology combines multiple analytical inputs:
- Fundamental analysis - financial statements, profitability ratios, debt structure, and cash flow metrics sourced from SEC filings and public financial reports
- Technical indicators - historical price patterns, momentum signals, and volatility measures
- Risk assessment - probability of bankruptcy models, market risk metrics, and downside scenario analysis
- Peer comparison - relative valuation against industry peers using standardized multiples
Model outputs are refreshed periodically as new financial data becomes available. Past model performance is not indicative of future results. The intrinsic value estimate reflects a point-in-time calculation and should be considered alongside other research and professional advice.
Data sourced from SEC filings (EDGAR), public financial statements, and market data providers.
Editorial review and methodology oversight provided by: Gabriel Shpitalnik, Member of Macroaxis Editorial Board
Growth Indicators
A growth thesis around Dolby Laboratories warrants careful testing because strong valuation often embeds the assumption that the business can keep compounding faster than peers. In practice, growth analysis separates durable compounding from optimism that may already be fully priced in.
| Common Stock Shares Outstanding | 97.48 million | |
| Quarterly Earnings Growth Y O Y | 5.30% | |
| Forward Price Earnings | 14.1044 |
Dolby Laboratories Current Valuation Indicators
The intrinsic value of Dolby Laboratories is estimated using multiple approaches, including discounted cash flow analysis, relative valuation multiples, and balance sheet-based methods, each reflecting different assumptions about earnings durability, capital structure, and future cash generation. Quantitative valuation narrows the range of reasonable outcomes by cross-referencing multiple model-based signals. Reported values are derived from company filings, audited financial statements, and market data, and are standardized within Macroaxis quantitative models for consistency. Model outputs reflect a point-in-time estimate based on available data and assumptions and should be interpreted alongside changes in operating performance, market conditions, and forward expectations.